Home Increase of Anti-Metastatic Efficacy by Selectivity- But Not Affinity-Optimization of Synthetic Serine Protease Inhibitors
Article
Licensed
Unlicensed Requires Authentication

Increase of Anti-Metastatic Efficacy by Selectivity- But Not Affinity-Optimization of Synthetic Serine Protease Inhibitors

  • I. J. Banke , M. J. E. Arlt , C. Pennington , C. Kopitz , T. Steinmetzer , A. Schweinitz , B. Gansbacher , J. P. Quigley , D. R. Edwards , J. Stürzebecher and A. Krüger
Published/Copyright: June 1, 2005

Abstract

Although tumors frequently show elevated protease activities, the concept of anti-proteolytic cancer therapy has lost momentum after failure of clinical trials with broad-spectrum matrix metalloproteinase inhibitors. Thus we need to adapt our design strategies for protease inhibitors. Here, we employed a series of seven structurally fine-modulated and pharmacokinetically closely related synthetic 4-amidinobenzylamine based inhibitors with distinct selectivity for prototypical serine proteases in a murine T cell lymphoma liver metastasis model. This in vivo screening revealed efficacy of urokinase inhibitors but no correlation between urokinase selectivity or affinity and antimetastatic effect. In contrast, factor Xa-selective inhibitors were more potent, demonstrating factor Xa or a factor Xa-like serine protease likely to be more determinant in this model. Factor Xa selectivity, but not affinity, significantly improved antimetastatic efficacy. For example, factor Xa inhibitors CJ-504 and CJ-510 exert similar affinity for factor Xa (Ki=14 nM versus 8.8 nM) but CJ-504 was 70-fold more selective for factor Xa. This correlated with higher antimetastatic efficacy (58.8% with CJ-504; 28.2% with CJ-510). Our results show that among the protease inhibitors employed that have affinities in the nanomolar range, the strategy of selectivity-optimization is superior to further improvement of affinity to significantly enhance anti-metastatic efficacy. This appreciation may be important for the future rational design of new anti-proteolytic agents for cancer therapy.

:
Published Online: 2005-06-01
Published in Print: 2003-11-07

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Mechanisms and Biological Consequences of Nitrosative Stress
  2. Regulation of the Expression of Inducible Nitric Oxide Synthase
  3. Nitrosative Stress and Transcription
  4. Nitric Oxide Signalling with a Special Focus on Lipid-Derived Mediators
  5. Potential of Embryonic and Adult Stem Cells in vitro
  6. Ribosomal Tolerance and Peptide Bond Formation
  7. Transcription of Cathepsin B in Glioma Cells: Regulation by an E-Box Adjacent to the Transcription Initiation Site
  8. The Catalytically Active Domain in the A Subunit of Calcineurin
  9. HIV TAT Basic Peptide Is Not a High-Affinity Ligand for VEGF Receptor 2
  10. Immunogenicity and Protectivity of Plasmodium falciparum EBA-175 Peptide and Its Analog Is Associated with α-Helical Region Shortening and Displacement
  11. Gene Organization and Molecular Modeling of Copper Amine Oxidase from Aspergillus niger: Re-Evaluation of the Cofactor Structure
  12. Thermodynamic Analysis of the Dissociation of the Aldolase Tetramer Substituted at One or Both of the Subunit Interfaces
  13. Molecular Recognition between Azotobacter vinelandii Rhodanese and a Sulfur Acceptor Protein
  14. Cloning and Characterization of a Transmembrane-Type Serine Protease from Rat Kidney, a New Sodium Channel Activator
  15. Aptamers That Recognize the Lipid Moiety of the Antibiotic Moenomycin A
  16. Suboptimal Action of NF-κB in Fanconi Anemia Cells Results from Low Levels of Thioredoxin
  17. Modulation of the Activation of Extracellular Signal-Regulated Kinase (ERK) and the Production of Inflammatory Mediators by ADP-Ribosylation Inhibitors
  18. Increase of Anti-Metastatic Efficacy by Selectivity- But Not Affinity-Optimization of Synthetic Serine Protease Inhibitors
  19. Mast Cell Cathepsins C and S Control Levels of Carboxypeptidase A and the Chymase, Mouse Mast Cell Protease 5
  20. Application of the C4'-Alkylated Deoxyribose Primer System (CAPS) in Allele-Specific Real-Time PCR for Increased Selectivity in Discrimination of Single Nucleotide Sequence Variants
Downloaded on 18.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2003.168/html
Scroll to top button